Laurence Van Melderen

Dr. Laurence Van Melderen


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2022 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
DJDukas Jurėnas
Dukas Jurėnas
NFNathan Fraikin
Nathan Fraikin
FGFrédéric Goormaghtigh
Frédéric Goormaghtigh
LMLaurence Van Melderen
Laurence Van Melderen

27 March 2009 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
LMLaurence Van Melderen
Laurence Van Melderen
MBManuel Saavedra De Bast
Manuel Saavedra De Bast
Bacterial toxin–antitoxin (TA) systems are diverse and widespread in the prokaryotic kingdom. They are composed of closely linked genes encoding a stable toxin that can harm the host cell and its cognate labile antitoxin, which protects the host from the toxin's deleterious effect. TA systems are thought to invade bacterial genomes through horizontal gene transfer. Some TA systems might behave as selfish elements and favour their own maintenance at the expense of their host. As a consequence, they may contribute to the maintenance of plasmids or genomic islands, such as super-integrons, by post-segregational killing of the cell that loses these genes and so suffers the stable toxin's destructive effect. The function of the chromosomally encoded TA systems is less clear and still open to debate. This Review discusses current hypotheses regarding the biological roles of these evolutionarily successful small operons. We consider the various selective forces that could drive the maintenance of TA systems in bacterial genomes.

21 March 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RLRaphaël Leplae
Raphaël Leplae
DGDamien Geeraerts
Damien Geeraerts
RHRégis Hallez
Régis Hallez
JGJulien Guglielmini
Julien Guglielmini
PDPierre Drèze
Pierre Drèze
LMLaurence Van Melderen
Laurence Van Melderen
Type II toxin–antitoxin (TA) systems are generally composed of two genes organized in an operon, encoding a labile antitoxin and a stable toxin. They were first discovered on plasmids where they contribute to plasmid stability by a phenomenon denoted as ‘addiction’, and subsequently in bacterial chromosomes. To discover novel families of antitoxins and toxins, we developed a bioinformatics approach based on the ‘guilt by association’ principle. Extensive experimental validation in Escherichia coli of predicted antitoxins and toxins increased significantly the number of validated systems and defined novel toxin and antitoxin families. Our data suggest that toxin families as well as antitoxin families originate from distinct ancestors that were assembled multiple times during evolution. Toxin and antitoxin families found on plasmids tend to be promiscuous and widespread, indicating that TA systems move through horizontal gene transfer. We propose that due to their addictive properties, TA systems are likely to be maintained in chromosomes even though they do not necessarily confer an advantage to their bacterial hosts. Therefore, addiction might play a major role in the evolutionary success of TA systems both on mobile genetic elements and in bacterial chromosomes.

1 December 2010 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
LMLaurence Van Melderen
Laurence Van Melderen

11 March 2020 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
NFNathan Fraikin
Nathan Fraikin
FGFrédéric Goormaghtigh
Frédéric Goormaghtigh
LMLaurence Van Melderen
Laurence Van Melderen
Type II toxin-antitoxin (TA) systems are small genetic elements composed of a toxic protein and its cognate antitoxin protein, the latter counteracting the toxicity of the former. While TA systems were initially discovered on plasmids, functioning as addiction modules through a phenomenon called postsegregational killing, they were later shown to be massively present in bacterial chromosomes, often in association with mobile genetic elements. Extensive research has been conducted in recent decades to better understand the physiological roles of these chromosomally encoded modules and to characterize the conditions leading to their activation.

4 May 2011 in Critical Reviews in Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
PDF file
FHFinbarr Hayes
Finbarr Hayes
LMLaurence Van Melderen
Laurence Van Melderen
Genes for toxin-antitoxin (TA) complexes are widespread in prokaryote genomes, and species frequently possess tens of plasmid and chromosomal TA loci. The complexes are categorized into three types based on genetic organization and mode of action. The toxins universally are proteins directed against specific intracellular targets, whereas the antitoxins are either proteins or small RNAs that neutralize the toxin or inhibit toxin synthesis. Within the three types of complex, there has been extensive evolutionary shuffling of toxin and antitoxin genes leading to considerable diversity in TA combinations. The intracellular targets of the protein toxins similarly are varied. Numerous toxins, many of which are sequence-specific endoribonucleases, dampen protein synthesis levels in response to a range of stress and nutritional stimuli. Key resources are conserved as a result ensuring the survival of individual cells and therefore the bacterial population. The toxin effects generally are transient and reversible permitting a set of dynamic, tunable responses that reflect environmental conditions. Moreover, by harboring multiple toxins that intercede in protein synthesis in response to different physiological cues, bacteria potentially sense an assortment of metabolic perturbations that are channeled through different TA complexes. Other toxins interfere with the action of topoisomersases, cell wall assembly, or cytoskeletal structures. TAs also play important roles in bacterial persistence, biofilm formation and multidrug tolerance, and have considerable potential both as new components of the genetic toolbox and as targets for novel antibacterial drugs.